Mechanistically, BTZ‐ and CFZ‐resistant MM cells exhibit increased activation of the IRE1α/XBP1s arm of the UPR pathways,[47] which can be suppressed by ZMYND8. Here, ZMYND8 is linked to Miyoshi myopathy.